Piramal Pharma Share Price Target 2026,2030,2035,2040

Share of Piramal Pharma Limited is currently trading at around Rs.167/-. Investors are asking for the Piramal Pharma Share Price Target for 2026, 2030, 2035 and 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Piramal Pharma Share Price Target for 2026, 2030, 2035 and 2040.

Discussion & Analysis of Business & Financial performance with future business prospects of Piramal Pharma Ltd:

Piramal Pharma Limited (PPL) is one of India’s leading pharmaceutical companies with a diversified presence across Contract Development and Manufacturing Organization (CDMO) services, complex hospital generics, and consumer healthcare products. Following its demerger from Piramal Enterprises Limited, the company has established itself as a global pharmaceutical player with operations spanning North America, Europe, Asia, and other international markets.

At present, Piramal Pharma derives a significant portion of its revenue from its CDMO business, which provides research, development, and manufacturing services to global pharmaceutical and biotechnology companies. The company has built strong capabilities in high-value areas such as antibody-drug conjugates (ADCs), sterile injectables, active pharmaceutical ingredients (APIs), and complex drug formulations. Its extensive manufacturing network across India, the United States, Canada, and the United Kingdom strengthens its position as a trusted partner for global drug innovators.

The company’s Complex Hospital Generics segment focuses on critical care products, inhalation anesthetics, and injectable medicines, serving hospitals across several countries. Additionally, its Consumer Healthcare business owns well-known Indian brands in the self-care and over-the-counter healthcare segments, providing stable domestic revenue streams. This diversified business model reduces dependence on any single product category or market.

Looking ahead, Piramal Pharma’s future prospects appear promising. The global outsourcing trend in pharmaceutical manufacturing continues to grow as innovator companies seek cost-efficient and specialized manufacturing partners. This trend is expected to benefit Piramal Pharma’s CDMO business significantly. The company’s investments in advanced manufacturing technologies, biologics capabilities, and specialized drug delivery systems position it well to capture emerging opportunities in the pharmaceutical value chain.

Another important growth driver is the increasing demand for biologics, gene therapies, and complex injectable products. Piramal Pharma has already invested in these high-growth areas and is expected to benefit from rising customer demand over the next decade. Capacity expansions across several facilities could further support revenue growth and improve operating leverage.

The consumer healthcare business also offers long-term potential due to rising healthcare awareness, growing disposable incomes, and increasing demand for self-medication products in India. Strong brand recognition and distribution networks can help the company strengthen its market position in this segment.

However, investors should monitor challenges such as regulatory compliance requirements, pricing pressures in global pharmaceutical markets, currency fluctuations, and competition from other international CDMO players. Any delays in regulatory approvals or customer project execution could affect short-term performance.

Overall, Piramal Pharma Limited is well-positioned to benefit from the long-term growth of the global pharmaceutical outsourcing industry. Its diversified business portfolio, strong manufacturing capabilities, expanding global presence, and focus on high-value pharmaceutical segments provide a solid foundation for sustainable growth in the coming years.

Share Price Targets:

Piramal Pharma Share Price Target 2026

Based on the above discussion and analysis, the share price of Piramal Pharma Ltd may touch the level of around Rs.185-200 in 2026

Piramal Pharma Share Price Target 2030

Based on the above discussion and analysis, the share price of Piramal Pharma Ltd may touch the level of around Rs.375-400 in 2030

Piramal Pharma Share Price Target 2035

Based on the above discussion and analysis, the share price of Piramal Pharma Ltd may touch the level of around Rs.800–850 in 2035

Piramal Pharma Share Price Target 2040

Based on the above discussion and analysis, the share price of Piramal Pharma Ltd may touch the level of around Rs.1700-1800 in 2040

Disclaimer: Investments in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. News4You does not offer investment advice and does not encourage any action based on its content.

Read Also: